J.P. Morgan reports that in the area of health care IT, its two top picks for 2011 are Accretive Health, Inc. AH and Allscripts Healthcare Solutions MDRX.
“We view AH as an underappreciated story with the best growth prospects in our coverage universe, and multiple expansion from current levels should drive the shares higher,” J.P. Morgan writes.
“For MDRX, we believe management's 2011 guidance is conservative, and outperformance should drive the shares higher.”
Allscripts Healthcare Solutions closed at closed Wednesday at $20.13; Accretive Health closed at $16.50.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in